Oncology Clinical Pathways Spotlight
This week in health care trends, our oncology clinical pathways spotlight includes a new payment model proposal for CMS, value-based care in oncology, CMS’s new QRS and QHP Enrollee Experience Survey, a survey of mammogram prices across the U.S., and are Exchange participants happy with their network options?
As a new update in the ACO experiment, one analysis has found that “four years of nation-wide testing by The Centers for Medicare and Medicaid Services (CMS) has now proven that the current shared savings payment models do not work effectively for low-cost Accountable Care Organizations (ACOs).” This article argues that CMS’s Shared Savings program is not working and proposes its own “global risk-adjusted payment system.”
In this short video, Andrew L. Pecora, MD explains why determining the cost and value of drugs is so complex, and why getting patients coverage can be complicated as well.
This analysis by Data Monitor Healthcare takes a look at “the implications of clinical pathways in oncology” and strategies for pharma companies to effectively deal with pathways.
At the end of September, CMS released two important documents: its Quality Rating System (QRS) and Quality Health Plan (QHP) Enrollee Experience Survey: Technical Guidance for 2016 as well as its 2016 QRS Measure Technical Specifications.
A new report comparing the prices of mammograms in the U.S.’s 30 largest cities has found “a 44x variation in the cost of a mammogram across the 30 cities, ranging from $43 (Sarasota-Bradenton, FL) to $1898 (NY, Northern NJ, Long Island).”
Another ACA open enrollment period is approaching, so let’s take a look at this survey that set out to determine “whether plan offerings reflect consumer preferences.”
The articles above are from our dedicated Oncology Clinical Pathways e-magazine. Follow us on Flipboard or Twitter, or just watch for the links to this and our other magazines in our regular weekly BioBlog emails. (Don’t get our emails yet? Subscribe here!)